A detailed history of Janiczek Wealth Management, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 8,211 shares of RDY stock, worth $116,596. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,211
Previous 6,177 32.93%
Holding current value
$116,596
Previous $453,000 37.97%
% of portfolio
0.13%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$68.26 - $76.19 $138,840 - $154,970
2,034 Added 32.93%
8,211 $625,000
Q1 2024

Apr 15, 2024

BUY
$67.36 - $77.59 $117,206 - $135,006
1,740 Added 39.22%
6,177 $453,000
Q4 2023

Jan 26, 2024

BUY
$64.27 - $69.9 $44,024 - $47,881
685 Added 18.26%
4,437 $308,000
Q3 2023

Oct 13, 2023

BUY
$61.9 - $72.77 $22,284 - $26,197
360 Added 10.61%
3,752 $250,000
Q2 2023

Jul 11, 2023

BUY
$53.34 - $63.11 $17,602 - $20,826
330 Added 10.78%
3,392 $214,000
Q1 2023

Apr 21, 2023

BUY
$51.63 - $56.93 $13,630 - $15,029
264 Added 9.44%
3,062 $174,000
Q4 2022

Jan 20, 2023

BUY
$51.15 - $57.45 $10,332 - $11,604
202 Added 7.78%
2,798 $0
Q3 2022

Oct 17, 2022

BUY
$49.9 - $57.32 $43,912 - $50,441
880 Added 51.28%
2,596 $136,000
Q2 2022

Aug 03, 2022

SELL
$49.62 - $58.13 $16,920 - $19,822
-341 Reduced 16.58%
1,716 $88,000
Q1 2022

May 05, 2022

BUY
$48.27 - $65.25 $48,897 - $66,098
1,013 Added 97.03%
2,057 $115,000
Q4 2021

Feb 02, 2022

BUY
$59.5 - $67.25 $18,861 - $21,318
317 Added 43.6%
1,044 $68,000
Q3 2021

Oct 19, 2021

SELL
$60.19 - $75.29 $7,162 - $8,959
-119 Reduced 14.07%
727 $47,000
Q2 2021

Jul 28, 2021

BUY
$62.12 - $74.2 $12,858 - $15,359
207 Added 32.39%
846 $62,000
Q1 2021

Apr 28, 2021

BUY
$57.98 - $73.08 $13,219 - $16,662
228 Added 55.47%
639 $39,000
Q4 2020

Jan 26, 2021

BUY
$62.61 - $71.29 $16,716 - $19,034
267 Added 185.42%
411 $29,000
Q3 2020

Oct 19, 2020

BUY
$51.39 - $72.41 $7,400 - $10,427
144 New
144 $10,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.36B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.